Shrewsbury, MA, United States of America

Chrisantha Hugh Senanayake

USPTO Granted Patents = 24 (Patent Applications = 3)

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 3

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 240(Granted Patents)

Location History:

Shrewsburry, MA (US) (2002)
Shrewsbury, MA (US) (1998 - 2015)

Company Filing History:

Sunovion Pharmaceuticals Inc.

5. 1 out of 832,680

Other

patents

Years Active: 1998-2015

Loading Chart...

24 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9072700 - Methods of using derivatives of (−)-venlafaxine (2015-07-07),

2. 8642662 - Methods of using derivatives of (−)-venlafaxine (2014-02-04),

3. 8269040 - Derivatives of venlafaxine and methods of preparing and using the same (2012-09-18),

4. 7071234 - Methods of treating or preventing erectile dysfunction (2006-07-04),

5. 7034059 - Methods of using norfluoxetine (2006-04-25),

6. 6974838 - Methods of treating or preventing pain using sibutramine metabolites (2005-12-13),

7. 6974837 - Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors (2005-12-13),

8. 6946464 - Methods of treating and preventing a convulsive state (2005-09-20),

9. 6911479 - Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (−)-venlafaxine (2005-06-28),

10. 6710087 - Methods of treating or preventing neuropathic pain using sibutramine metabolites (2004-03-23),

11. 6538034 - Methods of treating or preventing weight gain, obesity, and related disorders (2003-03-25),

12. 6506753 - Methods of making and using N-desmethylzopiclone (2003-01-14),

13. 6476078 - Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction (2002-11-05),

14. 6458791 - Methods of treating muscle spasms using N-desmethylzopiclone (2002-10-01),

15. 6441048 - Methods of treating affective disorders using derivatives of (-)-venlafaxine (2002-08-27),

Title: Innovations in Pharmacology: The Impact of Chrisantha Hugh Senanayake

Introduction

Chrisantha Hugh Senanayake, based in Shrewsbury, Massachusetts, is a notable inventor in the field of pharmacology with an impressive portfolio of 24 patents. His work primarily focuses on developing innovative methods and compositions that are aimed at treating a variety of challenging diseases and disorders, particularly those affecting mental health and cognition.

Latest Patents

Some of Senanayake's latest patents include groundbreaking methods of using derivatives of (−)-venlafaxine. These patents describe comprehensive methods of preparing and utilizing these derivatives in compositions aimed at treating and preventing various diseases. Significant conditions highlighted in his patents include, but are not limited to, affective disorders such as depression, bipolar and manic disorders, attention deficit disorder (with and without hyperactivity), Parkinson's disease, epilepsy, cerebral function disorders, obesity, weight gain, incontinence, dementia, and related disorders.

Career Highlights

Throughout his career, Chrisantha Senanayake has made significant contributions while working with prominent companies such as Sepracor, Inc. and Sunovion Pharmaceuticals Inc. His innovative approaches to drug development have not only advanced pharmacological research but have also improved treatment options for patients suffering from various ailments.

Collaborations

Collaboration has been a vital aspect of Senanayake's career. He has worked alongside talented individuals like Thomas P. Jerussi and Qun Kevin Fang, contributing to the advancement of their collective knowledge and innovation in pharmaceutical sciences. These partnerships highlight the importance of teamwork in achieving groundbreaking discoveries in the field.

Conclusion

In summary, Chrisantha Hugh Senanayake is an influential inventor whose work has significantly impacted the realm of pharmacology. His relentless pursuit of improving medical treatments through innovative inventions underscores the importance of collaboration, creativity, and dedication in the quest to address complex health challenges. As research continues to evolve, Senanayake's contributions remain instrumental in paving the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.